ATRA vs AZO · rev $128.9M vs P/E 21, rev $18.94B
Atara Biotherapeutics Inc (ATRA) versus AutoZone Inc (AZO) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. Revenue was up 2.4% from 2024-08-31 to 2025-08-30. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
ATRA currently screens at market cap $87.1M. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Not investment advice. Open the ATRA and AZO stock pages for the full models.
Not investment advice.